SEC Form 4 · accession 0001144204-17-029536
BIOHITECH GLOBAL, INC. · BHTG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank E. Celli
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
May 24, 2017
Accepted (ET)
May 25, 2017 · 2:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590383
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF2,F1 | $3.00 | May 24, 2017 | X | 1 | A | May 24, 2017 | May 24, 2018 | Common Stock | 213,333 | 1 | D |
| WarrantsF3 | $3.75 | May 24, 2017 | X | 85,333 | A | May 24, 2017 | May 24, 2022 | Common Stock | 85,333 | 85,333 | D |
Explanation of responses
- F1Represents the number of shares of common stock, par value $0.001 per share (the "Common Stock") into which the note is convertible based on the conversion price of $3.00 per share.
- F2Does not include: 1,293,685 shares of common stock held by the reporting person; 670,303 shares of common stock underlying convertible debentures or warrants to purchase an additional 670,303 shares of common stock held by the reporting person.
- F3Represents the number of shares of Common Stock into which the warrants are exercisable based on the exercise price of $3.75 per share.